Crossmark

Mitogen-activated protein kinase inhibitor-associated retinopathy (MEKAR). A clinical case

Crossref DOI link: https://doi.org/10.1016/j.oftale.2022.02.006

Published Print: 2022-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Buenasmañanas-Maeso, M.

Gutiérrez-Montero, Ó.

Reche-Sainz, J.A.

Badillo Arcones, E.

Monja-Alarcón, N.

Toledano-Fernández, N.
License Information

Text and Data Mining valid from 2022-05-01
More Information

This article is maintained by: Elsevier

Article Title: Mitogen-activated protein kinase inhibitor-associated retinopathy (MEKAR). A clinical case

Journal Title: Archivos de la Sociedad Española de Oftalmología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.oftale.2022.02.006

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.oftal.2021.03.004

Content Type: simple-article

Copyright: © 2021 Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U. All rights reserved.